Cancer risk in IBD: How to diagnose and how to manage DALM and ALM

doi:10.3748/wjg.v17.i27.3184

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5406)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

650

HTML

4236

Figures (1-7)

304

Tables (1-1)

216

Sum=5406

Jul 21, 2011 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jul 21, 2011; 17(27): 3184-3191
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3184

Full Size Figure Download Figure

Figure 5 Fluorescein-guided confocal laser endomicroscopy (iCLE, Pentax, Tokyo, Japan) of dysplasia-associated lesion or mass. Endomicroscopy visualizes tubular architecture and enlarged cells with depletion of goblet cells. The shape and size of the crypts is irregular, and leakage, demonstrated by the extravasation of fluorescein, is visible.

Citation: Neumann H, Vieth M, Langner C, Neurath MF, Mudter J. Cancer risk in IBD: How to diagnose and how to manage DALM and ALM. World J Gastroenterol 2011; 17(27): 3184-3191
URL: https://www.wjgnet.com/1007-9327/full/v17/i27/3184.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i27.3184